| Literature DB >> 28596207 |
Sunila Jain1, Neel Gautam Jain2.
Abstract
Chloroquine-induced maculopathy may progress years after drug cessation and an apparent period of visual stability. Both doctor and patients should be fully aware of the risks of retinal toxicity, including delayed onset and progression. It is therefore crucial that regular monitoring continues in affected patients, long after the initial diagnosis of maculopathy. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: Drugs: musculoskeletal and joint diseases; Eye
Mesh:
Substances:
Year: 2017 PMID: 28596207 PMCID: PMC5535135 DOI: 10.1136/bcr-2017-220598
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X